These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6454383)

  • 1. Pharmacokinetics of moxalactam in patients with renal insufficiency.
    Lam M; Manion CV; Czerwinski AW
    Antimicrob Agents Chemother; 1981 Mar; 19(3):461-4. PubMed ID: 6454383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction.
    Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA
    Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxalactam pharmacokinetics during hemodialysis.
    Aronoff GR; Sloan RS; Mong SA; Luft FC; Kleit SA
    Antimicrob Agents Chemother; 1981 Apr; 19(4):575-7. PubMed ID: 6454386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.
    Israel KS; Black HR; Brier GL; Wolny JD; DeSante KA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):94-102. PubMed ID: 6214998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of moxalactam in patients with normal and impaired renal function.
    Aronoff GR; Sloan RS; Luft FC
    J Infect Dis; 1982 Mar; 145(3):365-9. PubMed ID: 6460824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP
    Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
    Srinivasan S; Neu HC
    Antimicrob Agents Chemother; 1981 Sep; 20(3):398-400. PubMed ID: 6458236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative pharmacokinetics of moxalactam and other cephalosporins].
    Fourtillan JB; Brisson AM
    Sem Hop; 1983 Jun; 59(26):1968-71. PubMed ID: 6310788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
    Singlas E; Boutron HF; Merdjan H; Brocard JF; Pocheville M; Fries D
    Clin Pharmacol Ther; 1983 Sep; 34(3):403-7. PubMed ID: 6224624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects.
    Peterson LR; Bean B; Fasching CE; Korchik WP; Gerding DN
    Antimicrob Agents Chemother; 1981 Sep; 20(3):378-81. PubMed ID: 6458235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.
    Srinivasan S; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
    Scheld WM; Spyker DA; Donowitz GR; Bolton WK; Sande MA
    Antimicrob Agents Chemother; 1981 Apr; 19(4):613-9. PubMed ID: 6454387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxalactam--absorption, excretion, distribution, and metabolism.
    Shimada J; Ueda Y
    Rev Infect Dis; 1982; 4 Suppl():S569-80. PubMed ID: 6218568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxalactam kinetics in hemodialysis.
    Jacobson EJ; Zahrowski JJ; Nissenson AR
    Clin Pharmacol Ther; 1981 Oct; 30(4):487-90. PubMed ID: 6456860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of moxalactam in adults].
    Humbert G; Leroy A; Fillastre JP
    Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers.
    Parsons JN; Romano JM; Levison ME
    Antimicrob Agents Chemother; 1980 Feb; 17(2):226-8. PubMed ID: 6446259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.
    Lüthy R; Blaser J; Bonetti A; Simmen H; Wise R; Siegenthaler W
    Antimicrob Agents Chemother; 1981 Nov; 20(5):567-75. PubMed ID: 6275776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of probenecid on the pharmacokinetics of moxalactam.
    DeSante KA; Israel KS; Brier GL; Wolny JD; Hatcher BL
    Antimicrob Agents Chemother; 1982 Jan; 21(1):58-61. PubMed ID: 6211135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of moxalactam in renal failure.
    Wright N; Wills PJ; Wise R
    J Antimicrob Chemother; 1981 Nov; 8(5):395-9. PubMed ID: 6459316
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic and clinical evaluation of moxalactam in infants and children.
    Latif R; Thirumoorthi MC; Buckley JA; Kobos DM; Aravind MK; Kauffman RE; Dajani AS
    Dev Pharmacol Ther; 1981; 3(4):222-31. PubMed ID: 6212231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.